Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Charmacy Pharmaceutical Co., Ltd. (2289.HK)

HKSE - HKSE Delayed Price. Currency in HKD
7.2900.000 (0.00%)
At close: 11:38AM HKT
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in HKD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 4/2/2023
Current
Market Cap (intraday)
N/A
Enterprise Value
N/A
Trailing P/E
N/A
Forward P/E
N/A
PEG Ratio (5 yr expected)
N/A
Price/Sales (ttm)
N/A
Price/Book (mrq)
N/A
Enterprise Value/Revenue
N/A
Enterprise Value/EBITDA
N/A

Trading Information

Stock Price History

Beta (5Y Monthly) -0.05
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 38.200
52 Week Low 34.810
50-Day Moving Average 37.204
200-Day Moving Average 37.296

Share Statistics

Avg Vol (3 month) 3174.38k
Avg Vol (10 day) 3150
Shares Outstanding 5108M
Implied Shares Outstanding 6N/A
Float 817.8M
% Held by Insiders 180.55%
% Held by Institutions 15.00%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.20
Trailing Annual Dividend Yield 32.74%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4Jun 02, 2021
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in CNY.

Fiscal Year

Fiscal Year Ends Dec 31, 2021
Most Recent Quarter (mrq)Jun 30, 2022

Profitability

Profit Margin 0.48%
Operating Margin (ttm)1.68%

Management Effectiveness

Return on Assets (ttm)1.44%
Return on Equity (ttm)3.46%

Income Statement

Revenue (ttm)3.69B
Revenue Per Share (ttm)34.15
Quarterly Revenue Growth (yoy)-5.30%
Gross Profit (ttm)237.22M
EBITDA 88.56M
Net Income Avi to Common (ttm)17.83M
Diluted EPS (ttm)N/A
Quarterly Earnings Growth (yoy)-20.50%

Balance Sheet

Total Cash (mrq)454.55M
Total Cash Per Share (mrq)4.21
Total Debt (mrq)1.14B
Total Debt/Equity (mrq)217.46
Current Ratio (mrq)1.05
Book Value Per Share (mrq)4.65

Cash Flow Statement

Operating Cash Flow (ttm)58.82M
Levered Free Cash Flow (ttm)207.39M
Advertisement
Advertisement